Introduction: The previously published European Association of Nuclear Medicine (EANM) paediatric dosage card recommends 70 MBq F-18 or F-18 Fluoro-2-Deoxyglucose (F-18-FDG) as the "minimum recommended activity".
Discussion: Two recent publications demonstrate that when utilising F-18-labelled radiopharmaceuticals the administration of lower activities for small children is possible without losing image quality.
Conclusion: In the light of these findings the EANM dosimetry and paediatrics committee have decided to reduce the value for the "minimum recommended activity" for both F-18 and F-18-FDG to 26 MBq for 2D- and 14 MBq for 3D-acquisitions.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00259-008-0799-9 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Article Synopsis
- The European Cancer Organisation's Essential Requirements for Quality Cancer Care (ERQCC) provide guidance on how to improve cancer treatment, focusing on ovarian cancer specifically.
- Ovarian cancer patients experience low cure rates due to inconsistent treatment and a need for specialized care, which should be provided in dedicated centers by qualified professionals.
- Centralized, patient-centered care throughout the entire treatment journey is essential for better outcomes but is not yet widely implemented across many European countries.
Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands: version 1.0.
Eur J Nucl Med Mol Imaging
October 2024
Institute of Neuroscience and Medicine (INM-3), Research Center Juelich, Juelich, Germany.
Purpose: To provide practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor (SSTR) ligands.
Methods: This joint practice guideline/procedure standard was collaboratively developed by the European Association of Nuclear Medicine (EANM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI), the European Association of Neurooncology (EANO), and the PET task force of the Response Assessment in Neurooncology Working Group (PET/RANO).
Results: Positron emission tomography (PET) using somatostatin receptor (SSTR) ligands can detect meningioma tissue with high sensitivity and specificity and may provide clinically relevant information beyond that obtained from structural magnetic resonance imaging (MRI) or computed tomography (CT) imaging alone.
EANM practice guidelines for an appropriate use of PET and SPECT for patients with epilepsy.
Eur J Nucl Med Mol Imaging
June 2024
Nuclear Medicine Department, University Hospital, Inserm, CHU Lille, U1172-LilNCog-Lille, F-59000, Lille, France.
Epilepsy is one of the most frequent neurological conditions with an estimated prevalence of more than 50 million people worldwide and an annual incidence of two million. Although pharmacotherapy with anti-seizure medication (ASM) is the treatment of choice, ~30% of patients with epilepsy do not respond to ASM and become drug resistant. Focal epilepsy is the most frequent form of epilepsy.
View Article and Find Full Text PDFAnalysis of image data from the EuroNet PHL-C2 trial indicates a potential reduction in injected F-18 FDG activities in children: a proposal to update the EANM Paediatric Dosage Card.
Eur J Nucl Med Mol Imaging
January 2024
Department of Nuclear Medicine, University Hospital Leipzig, Leipzig, Germany.
Background: The aim of this work is to provide the currently missing evidence that may allow an update of the Paediatric Dosage Card provided by the European Association of Nuclear Medicine (EANM) for conventional PET/CT systems.
Methods: In a total of 2082 consecutive [F]FDG-PET scans performed within the EuroNet-PHL-C2 trial, the administered [F]FDG activity was compared to the activity recommended by the EANM Paediatric Dosage Card. None of these scans had been rejected beforehand by the reference nuclear medicine panel of the trial because of poor image quality.
European Cancer Organisation Essential Requirements for Quality Cancer Care: Adult glioma.
J Cancer Policy
December 2023
European Society for Radiotherapy and Oncology (ESTRO), Antwerp, Belgium; Iridium Netwerk and University of Antwerp, Antwerp, Belgium.
European Cancer Organisation Essential Requirements for Quality Cancer Care (ERQCCs) are explanations of the organisation and actions necessary to provide high-quality care to patients with a specific cancer type. They are compiled by a working group of European experts representing disciplines involved in cancer care, and provide oncology teams, patients, policymakers and managers with an overview of the essential requirements in any healthcare system. The focus here is on adult glioma.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!